Artículos de revistas
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
Fecha
2019Registro en:
Journal of Allergy and Clinical Immunology, Volumen 143, Issue 3, 2019, Pages 864-879
10976825
00916749
10.1016/j.jaci.2018.08.049
Autor
Bousquet, Jean
Hellings, Peter W.
Agache, Ioana
Amat, Flore
Annesi-Maesano, Isabella
Ansotegui, Ignacio J.
Anto, Josep M.
Bachert, Claus
Bateman, Eric D.
Bedbrook, Anna
Bennoor, Kazi
Bewick, Mickael
Bindslev-Jensen, Carsten
Bosnic-Anticevich, Sinthia
Boss
Institución
Resumen
© 2018 American Academy of Allergy, Asthma & ImmunologyAllergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-b